Citigroup’s Immunogen Inc IMGN Stock Holding History

Citigroup’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,900	Closed	-$20K	–	7814
2019 Q4	$20K	Sell	3,900 -1,200	-24%	-$4.07K	﹤0.01%	6935
2019 Q3	$12K	Sell	5,100 -700	-12%	-$1.86K	﹤0.01%	7000
2019 Q2	$13K	Sell	5,800 -30,000	-84%	-$70.9K	﹤0.01%	7237
2019 Q1	$97K	Buy	35,800 +24,400	+214%	+$106K	﹤0.01%	5773
2018 Q4	$55K	Buy	11,400 +8,600	+307%	+$52.2K	﹤0.01%	6161
2018 Q3	$27K	Sell	2,800 -6,000	-68%	-$57.7K	﹤0.01%	6945
2018 Q2	$86K	Buy	8,800 +7,400	+529%	+$78K	﹤0.01%	5853
2018 Q1	$15K	Buy	+1,400	New	+$13.8K	﹤0.01%	6890

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citigroup's IMGN Position: Q1 2024 in Review

Citigroup sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 337,743 shares — an estimated $10M sold.

Citigroup first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $10M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Citigroup reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Citigroup sold 337,743 Immunogen Inc shares in Q1 2024, an estimated $10M.
Citigroup first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
Citigroup's Immunogen Inc position peaked at $10M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.